Corentin du Roy joined HarbourVest's London-based subsidiary in 2003 as an analyst and became a principal in 2010. Corentin currently focuses on direct equity and credit transactions in Europe, Asia Pacific, and emerging markets. He played a key role in the launch of HarbourVest Senior Loans Europe Limited ("HSLE"), a closed-end investment company listed on the London Stock Exchange that invests in senior loans issued by European mid-market companies. He serves as a director or observer director of Envivio, Flash Networks, and Kiala. He also serves on the advisory committees for partnerships managed by Ciclad and Innovacom. He has been involved in HarbourVest's direct investments in Betapharm (acquired by Dr. Reddy's Laboratories), Cramer Systems (acquired by Amdocs), Finjan, GTS Central Europe, and Loxam, among others.
He joined the Firm from AXA Investment Managers, where he was an equity and high-yield debt research analyst focusing mainly on the telecom sector.
Fluent in French, Corentin received a BS (with distinction) in Business Administration from Paris IX Dauphine University in 1999 and received the Chartered Financial Analyst designation in 2002.
HarbourVest Partners (U.K.) Limited
